Literature DB >> 22568718

Invasive fungal infections in solid organ transplant recipients.

Shmuel Shoham1, Kieren A Marr.   

Abstract

Invasive fungal infections are a major problem in solid organ transplant (SOT) recipients. Overall, the most common fungal infection in SOT is candidiasis, followed by aspergillosis and cryptococcosis, except in lung transplant recipients, where aspergillosis is most common. Development of invasive disease hinges on the interplay between host factors (e.g., integrity of anatomical barriers, innate and acquired immunity) and fungal factors (e.g., exposure, virulence and resistance to prophylaxis). In this article, we describe the epidemiology and clinical features of the most common fungal infections in organ transplantation. Within this context, we review recent advances in diagnostic modalities and antifungal chemotherapy, and their impact on evolving prophylaxis and treatment paradigms.

Entities:  

Mesh:

Year:  2012        PMID: 22568718      PMCID: PMC4222063          DOI: 10.2217/fmb.12.28

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  149 in total

1.  1,3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid.

Authors:  Monique A S H Mennink-Kersten; Adilia Warris; Paul E Verweij
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

2.  Donor-derived infections in solid organ transplant recipients.

Authors:  P A Grossi; J A Fishman
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

3.  Candida in solid organ transplant recipients.

Authors:  P G Pappas; F P Silveira
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

4.  Invasive aspergillosis in solid organ transplant recipients.

Authors:  N Singh; S Husain
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

5.  Coccidioidomycosis after renal transplantation in an endemic area.

Authors:  C M Braddy; R L Heilman; J E Blair
Journal:  Am J Transplant       Date:  2006-02       Impact factor: 8.086

6.  Invasive aspergillosis in the recipients of liver retransplantation.

Authors:  Nina Singh; Timothy L Pruett; Sally Houston; Patricia Muñoz; Thomas V Cacciarelli; Marilyn M Wagener; Shahid Husain
Journal:  Liver Transpl       Date:  2006-08       Impact factor: 5.799

7.  Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.

Authors:  J F Castroagudín; C Pontón; M Bustamante; E Otero; J Martínez; S Tomé; R Conde; F R Segade; M Delgado; A Brage; C Galbán; E Varo
Journal:  Transplant Proc       Date:  2005-11       Impact factor: 1.066

8.  Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.

Authors:  Christopher D Pfeiffer; Jason P Fine; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2006-04-14       Impact factor: 9.079

9.  Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.

Authors:  Nina Singh; Ajit P Limaye; Graeme Forrest; Nasia Safdar; Patricia Muñoz; Kenneth Pursell; Sally Houston; Fernando Rosso; Jose G Montoya; Pamela Patton; Ramon Del Busto; Jose M Aguado; Robert A Fisher; Goran B Klintmalm; Rachel Miller; Marilyn M Wagener; Russell E Lewis; Dimitrios P Kontoyiannis; Shahid Husain
Journal:  Transplantation       Date:  2006-02-15       Impact factor: 4.939

10.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

View more
  38 in total

1.  Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic Fibrosis.

Authors:  Manon Launay; Antoine Roux; Laurence Beaumont; Benoit Douvry; Lucien Lecuyer; Emmanuel Douez; Clément Picard; Dominique Grenet; Vincent Jullien; Véronique Boussaud; Romain Guillemain; Eliane M Billaud
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Sepsis in the severely immunocompromised patient.

Authors:  Andre C Kalil; Steven M Opal
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

3.  Multicenter study evaluating the Vitek MS system for identification of medically important yeasts.

Authors:  Lars F Westblade; Rebecca Jennemann; John A Branda; Maureen Bythrow; Mary Jane Ferraro; Omai B Garner; Christine C Ginocchio; Michael A Lewinski; Ryhana Manji; A Brian Mochon; Gary W Procop; Sandra S Richter; Jenna A Rychert; Linda Sercia; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

4.  Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species.

Authors:  M A Pence; E McElvania TeKippe; M A Wallace; C-A D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-07       Impact factor: 3.267

5.  Donor Derived Candida stellimalicola in a Clinical Specimen: Preservation Fluid Contamination During Pancreas Procurement.

Authors:  Damien Dupont; Antoine Huguenin; Elodie Tisserand; Véronique Reiter; Emmanuel Morelon; Lionel Badet; Isabelle Villena; Martine Wallon; Dominique Toubas
Journal:  Mycopathologia       Date:  2017-07-05       Impact factor: 2.574

6.  Effects of a defective endoplasmic reticulum-associated degradation pathway on the stress response, virulence, and antifungal drug susceptibility of the mold pathogen Aspergillus fumigatus.

Authors:  Karthik Krishnan; Xizhi Feng; Margaret V Powers-Fletcher; Gregory Bick; Daryl L Richie; Laura A Woollett; David S Askew
Journal:  Eukaryot Cell       Date:  2013-01-25

7.  Novel Cell-Killing Mechanisms of Hydroxyurea and the Implication toward Combination Therapy for the Treatment of Fungal Infections.

Authors:  Amanpreet Singh; Ameeta Agarwal; Yong-Jie Xu
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

Review 8.  A Call to Arms: Quest for a Cryptococcal Vaccine.

Authors:  Marley C Caballero Van Dyke; Floyd L Wormley
Journal:  Trends Microbiol       Date:  2017-11-02       Impact factor: 17.079

9.  Cryptococcus neoformans osteomyelitis and intramuscular abscess in a liver transplant patient.

Authors:  Sonia Maria Poenaru; Rymon Rofaiel; Seyed M Hosseini-Moghaddam
Journal:  BMJ Case Rep       Date:  2017-10-11

10.  Troponoids Can Inhibit Growth of the Human Fungal Pathogen Cryptococcus neoformans.

Authors:  Maureen J Donlin; Anthony Zunica; Ashlyn Lipnicky; Aswin K Garimallaprabhakaran; Alex J Berkowitz; Alexandre Grigoryan; Marvin J Meyers; John E Tavis; Ryan P Murelli
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.